Cargando…
Safety of celecoxib versus traditional nonsteroidal anti-inflammatory drugs in older patients with arthritis
BACKGROUND: A 2011 systematic review found an increased cardiovascular (CV) risk at both ≤200 mg/day and >200 mg/day doses of celecoxib. This study aimed to evaluate adverse drug events with celecoxib relative to traditional nonsteroidal anti-inflammatory drugs (NSAIDs) in real-world practice set...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299466/ https://www.ncbi.nlm.nih.gov/pubmed/30588073 http://dx.doi.org/10.2147/JPR.S186000 |